Global Patent Index - EP 1082445 A2

EP 1082445 A2 2001-03-14 - ADENO-ASSOCIATED VIRAL VECTOR-MEDIATED EXPRESSION OF FACTOR VIII ACTIVITY

Title (en)

ADENO-ASSOCIATED VIRAL VECTOR-MEDIATED EXPRESSION OF FACTOR VIII ACTIVITY

Title (de)

EXPRESSION VON FAKTOR VIII DURCH AUF ADENO-ASSOZIIERTEN VIREN BASIERENDEN VEKTOREN

Title (fr)

EXPRESSION DE L'ACTIVITE DU FACTEUR VIII PAR UN VECTEUR VIRAL ADENO-ASSOCIE

Publication

EP 1082445 A2 (EN)

Application

EP 99925606 A

Priority

  • US 9910472 W
  • US 8442398 A

Abstract (en)

[origin: WO9961595A2] The instant invention provides methods and materials for expressing polypeptides with factor VIII activity comprising administering at least two rAAV vectors encoding different domains of human factor VIII and at least the heavy and light chains.

IPC 1-7 (main, further and additional classification)

C12N 15/86

IPC 8 full level (invention and additional information)

C12N 15/09 (2006.01); A61K 35/76 (2006.01); A61K 38/43 (2006.01); A61K 48/00 (2006.01); A61P 7/04 (2006.01); C07K 14/755 (2006.01); C12N 15/864 (2006.01)

CPC (invention and additional information)

A61K 48/00 (2013.01); C07K 14/755 (2013.01); C12N 15/86 (2013.01); C12N 2750/14143 (2013.01)

Citation (search report)

See references of WO 9961595A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9961595 A2 19991202; WO 9961595 A3 20000127; AU 4185699 A 19991213; CA 2329143 A1 19991202; EP 1082445 A2 20010314; JP 2002516345 A 20020604

INPADOC legal status


2006-09-27 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20060404

2004-03-24 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: AVIGEN, INC.

2003-11-19 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20031008

2001-03-14 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20001220

2001-03-14 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE